Influenza C virus infection in France.
Identifieur interne : 000718 ( Main/Exploration ); précédent : 000717; suivant : 000719Influenza C virus infection in France.
Auteurs : J C Manuguerra [France] ; C. Hannoun ; M. AymardSource :
- The Journal of infection [ 0163-4453 ] ; 1992.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Anticorps antiviraux (sang), Enfant (MeSH), Facteurs âges (MeSH), France (épidémiologie), Humains (MeSH), Immunoglobuline G (métabolisme), Infections à Orthomyxoviridae (immunologie), Infections à Orthomyxoviridae (épidémiologie), Influenzavirus C (immunologie), Nourrisson (MeSH), Nouveau-né (MeSH), Protéine A staphylococcique (isolement et purification), Protéine A staphylococcique (métabolisme), Sensibilité et spécificité (MeSH), Sujet âgé (MeSH), Test ELISA (MeSH), Tests d'hémagglutination (MeSH), Tests d'inhibition de l'hémagglutination (MeSH).
- MESH :
- immunologie : Infections à Orthomyxoviridae, Influenzavirus C.
- isolement et purification : Protéine A staphylococcique.
- métabolisme : Immunoglobuline G, Protéine A staphylococcique.
- sang : Anticorps antiviraux.
- épidémiologie : France, Infections à Orthomyxoviridae.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Facteurs âges, Humains, Nourrisson, Nouveau-né, Sensibilité et spécificité, Sujet âgé, Test ELISA, Tests d'hémagglutination, Tests d'inhibition de l'hémagglutination.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Factors (MeSH), Aged (MeSH), Antibodies, Viral (blood), Child (MeSH), Enzyme-Linked Immunosorbent Assay (MeSH), France (epidemiology), Hemagglutination Inhibition Tests (MeSH), Hemagglutination Tests (MeSH), Humans (MeSH), Immunoglobulin G (metabolism), Infant (MeSH), Infant, Newborn (MeSH), Influenzavirus C (immunology), Middle Aged (MeSH), Orthomyxoviridae Infections (epidemiology), Orthomyxoviridae Infections (immunology), Sensitivity and Specificity (MeSH), Staphylococcal Protein A (isolation & purification), Staphylococcal Protein A (metabolism).
- MESH :
- chemical , blood : Antibodies, Viral.
- geographic , epidemiology : France.
- chemical , isolation & purification : Staphylococcal Protein A.
- chemical , metabolism : Immunoglobulin G, Staphylococcal Protein A.
- epidemiology : Orthomyxoviridae Infections.
- immunology : Influenzavirus C, Orthomyxoviridae Infections.
- Adolescent, Adult, Age Factors, Aged, Child, Enzyme-Linked Immunosorbent Assay, Hemagglutination Inhibition Tests, Hemagglutination Tests, Humans, Infant, Infant, Newborn, Middle Aged, Sensitivity and Specificity.
Abstract
Little is known of the epidemiology of influenza C virus infections in western Europe and of the exact role of this agent in acute viral respiratory infections. Several tests may be used for detecting antibodies against this agent but the significance of their respective results is not clear. A total of 301 samples of serum was collected from persons aged from 4 months to 88 years living in France in 1988. The samples were tested for the presence of antibodies to influenza C virus by haemagglutination-inhibition (HI) tests and ELISA. The specificity of the results was checked by immunoblotting and by antibody absorption with staphylococcal protein A. Significant HI activity was found in 61% of the 301 samples tested, titres ranging from 20-320; 70% were positive by ELISA with titres ranging from 500 to 32,000. The population tested was divided into four age groups: 0-15 years; 16-30 years; 31-50 years and 51-88 years. The highest rates for positive samples were found in the 16-30 year group (76 and 79% by HI tests and ELISA respectively) as well as significant HI and ELISA geometric mean titres. Positive samples were less common in young children (46 and 50% by HI tests and ELISA respectively) and in the oldest group (44 and 54% respectively). The 31-50 years age group formed an intermediate class. The high prevalence of antibody as well as the significant titres indicate intense circulation of influenza C virus, especially among young adults.
DOI: 10.1016/0163-4453(92)91150-a
PubMed: 1312564
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza C virus infection in France.</title><author><name sortKey="Manuguerra, J C" sort="Manuguerra, J C" uniqKey="Manuguerra J" first="J C" last="Manuguerra">J C Manuguerra</name><affiliation wicri:level="3"><nlm:affiliation>National Influenza Reference Centre for Northern France, Institut Pasteur, Paris.</nlm:affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName><wicri:orgArea>National Influenza Reference Centre for Northern France, Institut Pasteur</wicri:orgArea></affiliation></author><author><name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name></author><author><name sortKey="Aymard, M" sort="Aymard, M" uniqKey="Aymard M" first="M" last="Aymard">M. Aymard</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1992">1992</date><idno type="RBID">pubmed:1312564</idno><idno type="pmid">1312564</idno><idno type="doi">10.1016/0163-4453(92)91150-a</idno><idno type="wicri:Area/Main/Corpus">000719</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000719</idno><idno type="wicri:Area/Main/Curation">000719</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000719</idno><idno type="wicri:Area/Main/Exploration">000719</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza C virus infection in France.</title><author><name sortKey="Manuguerra, J C" sort="Manuguerra, J C" uniqKey="Manuguerra J" first="J C" last="Manuguerra">J C Manuguerra</name><affiliation wicri:level="3"><nlm:affiliation>National Influenza Reference Centre for Northern France, Institut Pasteur, Paris.</nlm:affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName><wicri:orgArea>National Influenza Reference Centre for Northern France, Institut Pasteur</wicri:orgArea></affiliation></author><author><name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name></author><author><name sortKey="Aymard, M" sort="Aymard, M" uniqKey="Aymard M" first="M" last="Aymard">M. Aymard</name></author></analytic><series><title level="j">The Journal of infection</title><idno type="ISSN">0163-4453</idno><imprint><date when="1992" type="published">1992</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Age Factors (MeSH)</term><term>Aged (MeSH)</term><term>Antibodies, Viral (blood)</term><term>Child (MeSH)</term><term>Enzyme-Linked Immunosorbent Assay (MeSH)</term><term>France (epidemiology)</term><term>Hemagglutination Inhibition Tests (MeSH)</term><term>Hemagglutination Tests (MeSH)</term><term>Humans (MeSH)</term><term>Immunoglobulin G (metabolism)</term><term>Infant (MeSH)</term><term>Infant, Newborn (MeSH)</term><term>Influenzavirus C (immunology)</term><term>Middle Aged (MeSH)</term><term>Orthomyxoviridae Infections (epidemiology)</term><term>Orthomyxoviridae Infections (immunology)</term><term>Sensitivity and Specificity (MeSH)</term><term>Staphylococcal Protein A (isolation & purification)</term><term>Staphylococcal Protein A (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Anticorps antiviraux (sang)</term><term>Enfant (MeSH)</term><term>Facteurs âges (MeSH)</term><term>France (épidémiologie)</term><term>Humains (MeSH)</term><term>Immunoglobuline G (métabolisme)</term><term>Infections à Orthomyxoviridae (immunologie)</term><term>Infections à Orthomyxoviridae (épidémiologie)</term><term>Influenzavirus C (immunologie)</term><term>Nourrisson (MeSH)</term><term>Nouveau-né (MeSH)</term><term>Protéine A staphylococcique (isolement et purification)</term><term>Protéine A staphylococcique (métabolisme)</term><term>Sensibilité et spécificité (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Test ELISA (MeSH)</term><term>Tests d'hémagglutination (MeSH)</term><term>Tests d'inhibition de l'hémagglutination (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Staphylococcal Protein A</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Immunoglobulin G</term><term>Staphylococcal Protein A</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à Orthomyxoviridae</term><term>Influenzavirus C</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenzavirus C</term><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Protéine A staphylococcique</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Immunoglobuline G</term><term>Protéine A staphylococcique</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>France</term><term>Infections à Orthomyxoviridae</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Child</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Hemagglutination Inhibition Tests</term><term>Hemagglutination Tests</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Middle Aged</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Facteurs âges</term><term>Humains</term><term>Nourrisson</term><term>Nouveau-né</term><term>Sensibilité et spécificité</term><term>Sujet âgé</term><term>Test ELISA</term><term>Tests d'hémagglutination</term><term>Tests d'inhibition de l'hémagglutination</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Little is known of the epidemiology of influenza C virus infections in western Europe and of the exact role of this agent in acute viral respiratory infections. Several tests may be used for detecting antibodies against this agent but the significance of their respective results is not clear. A total of 301 samples of serum was collected from persons aged from 4 months to 88 years living in France in 1988. The samples were tested for the presence of antibodies to influenza C virus by haemagglutination-inhibition (HI) tests and ELISA. The specificity of the results was checked by immunoblotting and by antibody absorption with staphylococcal protein A. Significant HI activity was found in 61% of the 301 samples tested, titres ranging from 20-320; 70% were positive by ELISA with titres ranging from 500 to 32,000. The population tested was divided into four age groups: 0-15 years; 16-30 years; 31-50 years and 51-88 years. The highest rates for positive samples were found in the 16-30 year group (76 and 79% by HI tests and ELISA respectively) as well as significant HI and ELISA geometric mean titres. Positive samples were less common in young children (46 and 50% by HI tests and ELISA respectively) and in the oldest group (44 and 54% respectively). The 31-50 years age group formed an intermediate class. The high prevalence of antibody as well as the significant titres indicate intense circulation of influenza C virus, especially among young adults.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1312564</PMID><DateCompleted><Year>1992</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0163-4453</ISSN><JournalIssue CitedMedium="Print"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>1992</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J. Infect.</ISOAbbreviation></Journal><ArticleTitle>Influenza C virus infection in France.</ArticleTitle><Pagination><MedlinePgn>91-9</MedlinePgn></Pagination><Abstract><AbstractText>Little is known of the epidemiology of influenza C virus infections in western Europe and of the exact role of this agent in acute viral respiratory infections. Several tests may be used for detecting antibodies against this agent but the significance of their respective results is not clear. A total of 301 samples of serum was collected from persons aged from 4 months to 88 years living in France in 1988. The samples were tested for the presence of antibodies to influenza C virus by haemagglutination-inhibition (HI) tests and ELISA. The specificity of the results was checked by immunoblotting and by antibody absorption with staphylococcal protein A. Significant HI activity was found in 61% of the 301 samples tested, titres ranging from 20-320; 70% were positive by ELISA with titres ranging from 500 to 32,000. The population tested was divided into four age groups: 0-15 years; 16-30 years; 31-50 years and 51-88 years. The highest rates for positive samples were found in the 16-30 year group (76 and 79% by HI tests and ELISA respectively) as well as significant HI and ELISA geometric mean titres. Positive samples were less common in young children (46 and 50% by HI tests and ELISA respectively) and in the oldest group (44 and 54% respectively). The 31-50 years age group formed an intermediate class. The high prevalence of antibody as well as the significant titres indicate intense circulation of influenza C virus, especially among young adults.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manuguerra</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>National Influenza Reference Centre for Northern France, Institut Pasteur, Paris.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hannoun</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Aymard</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013205">Staphylococcal Protein A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006386" MajorTopicYN="N">Hemagglutination Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009982" MajorTopicYN="Y">Influenzavirus C</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013205" MajorTopicYN="N">Staphylococcal Protein A</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1312564</ArticleId><ArticleId IdType="pii">0163-4453(92)91150-A</ArticleId><ArticleId IdType="doi">10.1016/0163-4453(92)91150-a</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Aymard, M" sort="Aymard, M" uniqKey="Aymard M" first="M" last="Aymard">M. Aymard</name><name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Manuguerra, J C" sort="Manuguerra, J C" uniqKey="Manuguerra J" first="J C" last="Manuguerra">J C Manuguerra</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000718 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000718 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:1312564
|texte= Influenza C virus infection in France.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:1312564" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeFranceV1
| This area was generated with Dilib version V0.6.35. |  |